Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CASI Pharmaceuticals

$2.2 Million Bet On Terns Pharmaceuticals? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones closed higher by around 193 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall…

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

CASI Pharmaceuticals's Return On Capital Employed Insights

Benzinga Pro data, CASI Pharmaceuticals (NASDAQ:CASI) reported Q1 sales of $9.06 million. Earnings fell to a loss of $8.40 million, resulting in a 55.7% decrease from last quarter.

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

CASI Pharmaceuticals: Q1 Earnings Insights

CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

inkl

Read news from The Economist, FT, and more,
with one subscription

Recap: CASI Pharmaceuticals Q1 Earnings

Recap: CASI Pharmaceuticals Q1 Earnings

CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

CASI Pharmaceuticals's Return On Capital Employed Insights

CASI Pharmaceuticals's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q4, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $9.16 million. Despite a 46.15% increase in earnings, the company posted a loss of $5.39 million.

Earnings Outlook For CASI Pharmaceuticals

Earnings Outlook For CASI Pharmaceuticals

CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that CASI Pharmaceuticals will report an earnings per share (EPS) of $-0.06.

How To Attend CASI Pharmaceuticals Q4 2021 Earnings Conference Call

How To Attend CASI Pharmaceuticals Q4 2021 Earnings Conference Call

CASI Pharmaceuticals (NASDAQ:CASI) will host a conference call at 08:00 AM ET on March 28, 2022, to discuss Q4 2021 earnings results.

Organisations

Genocea Biosciences

CASI Pharmaceuticals

Kala Pharmaceuticals

Mirati rapeutics

Avadel Pharmaceuticals

Better rapeutics

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play